Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-14-003491
Filing Date
2014-11-14
Accepted
2014-11-14 06:05:39
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cocp10q_sep302014.htm 10-Q 651723
2 MEMO OF UNDERSTANDING ex10-1.htm EX-10.1 85177
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER ex31-1.htm EX-31.1 12073
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER ex31-2.htm EX-31.2 12015
5 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION ex32-1.htm EX-32.1 7511
  Complete submission text file 0001415889-14-003491.txt   3622100

Data Files

Seq Description Document Type Size
6 cocp-20140930.xml EX-101.INS 418966
7 cocp-20140930.xsd EX-101.SCH 47117
8 cocp-20140930_cal.xml EX-101.CAL 39884
9 cocp-20140930_def.xml EX-101.DEF 62444
10 cocp-20140930_lab.xml EX-101.LAB 225166
11 cocp-20140930_pre.xml EX-101.PRE 175030
Mailing Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55158 | Film No.: 141220262
SIC: 2834 Pharmaceutical Preparations